Off‐label, but on‐evidence? A review of the level of evidence for pediatric pharmacotherapy

TM van der Zanden, NJL Smeets… - Clinical …, 2022 - Wiley Online Library
Many drugs are still prescribed off‐label to the pediatric population. Although off‐label drug
use not supported by high level of evidence is potentially harmful, a comprehensive …

Two decades of off-label prescribing in children: a literature review

S Balan, MAA Hassali, VSL Mak - World Journal of Pediatrics, 2018 - Springer
Background In the past two decades, many legislative and regulatory initiatives were taken
globally to improve drug use in children. However, children are still found to be prescribed …

Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society …

L Schrier, A Hadjipanayis, T Stiris… - European journal of …, 2020 - Springer
Health-care professionals who prescribe medicines have the professional duty to choose
medicines that are in the best interest of their individual patient, irrespective if that patient is …

[图书][B] A century of eugenics in America: From the Indiana experiment to the human genome era

PA Lombardo - 2011 - books.google.com
In 1907, Indiana passed the world's first involuntary sterilization law based on the theory of
eugenics. In time, more than 30 states and a dozen foreign countries followed suit. Although …

Benefit‐risk assessment of off‐label drug use in children: the bravo framework

TM van der Zanden, MG Mooij, NJ Vet… - Clinical …, 2021 - Wiley Online Library
A drug is granted a license for use after a thorough assessment of risks and benefits based
on high‐quality scientific proof of its efficacy and safety. Many drugs that are relevant to …

Going off-label without venturing off-course: evidence and ethical off-label prescribing

EA Largent, FG Miller, SD Pearson - Archives of Internal …, 2009 - jamanetwork.com
FOLLOWING US FOOD and Drug Administra-tion (FDA) approval, clinicians may lawfully
prescribe a drug or biologic agent for treatment regimens not specified in the approved …

Clinical innovation ethics frameworks: a systematic narrative review

M Wiersma, I Kerridge, W Lipworth - Health Policy, 2023 - Elsevier
Background It is common for doctors to engage in clinical innovation—ie to use novel
interventions that differ from standard practice, and that have not yet been shown to be safe …

Controlling off-label medication use

MR Gillick - Annals of Internal Medicine, 2009 - acpjournals.org
Off-label prescribing may lead to innovative new uses of old medications, is essential in
such fields as pediatrics, and avoids the lengthy and expensive process of modifying US …

Off-label prescribing in psychiatric practice

DS Baldwin, N Kosky - Advances in Psychiatric Treatment, 2007 - cambridge.org
Drug treatment is an essential part of much of psychiatric practice, in patients from a wide
age range, across many diagnostic groups and in a variety of settings. Despite the …

Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+

M Gazarian, DB Horton, B Carleton… - … and drug safety, 2023 - Wiley Online Library
Purpose Off‐label medicines use is a common and sometimes necessary practice in many
populations, with important clinical, ethical and financial consequences, including potential …